# | Title | Journal | Year | Citations |
---|
1 | International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer | Journal of Thrombosis and Haemostasis | 2013 | 469 |
2 | 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer | Lancet Oncology, The | 2019 | 458 |
3 | Haematological cancers in pregnancy | Lancet, The | 2012 | 321 |
4 | International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer | Lancet Oncology, The | 2016 | 315 |
5 | International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer | Journal of Thrombosis and Haemostasis | 2013 | 252 |
6 | 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 | Lancet Oncology, The | 2022 | 138 |
7 | Hematopoietic Stem Cell Transplantation—50 Years of Evolution and Future Perspectives | Rambam Maimonides Medical Journal | 2014 | 137 |
8 | Soluble plasma HLA peptidome as a potential source for cancer biomarkers | Proceedings of the National Academy of Sciences of the United States of America | 2010 | 127 |
9 | Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing | Nature Medicine | 2021 | 118 |
10 | Strikingly high false positivity of surveillance FDG‐PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era | American Journal of Hematology | 2013 | 78 |
11 | Non‐Hodgkin's lymphoma presenting as an endobronchial tumor: Report of eight cases and literature review | American Journal of Hematology | 2008 | 65 |
12 | Venetoclax in patients with acute myeloid leukemia refractory to hypomethylating agents—a multicenter historical prospective study | Annals of Hematology | 2019 | 56 |
13 | Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia | Leukemia | 2020 | 54 |
14 | Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases | American Journal of Hematology | 2020 | 53 |
15 | Rituximab-induced direct inhibition of T-cell activation | Cancer Immunology, Immunotherapy | 2012 | 50 |
16 | Reproductive organ involvement in non-Hodgkin lymphoma during pregnancy: a systematic review | Lancet Oncology, The | 2013 | 50 |
17 | Arterial thrombosis and cancer | Thrombosis Research | 2018 | 47 |
18 | Granulocyte transfusions for neutropenic patients with life‐threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions | Vox Sanguinis | 2007 | 42 |
19 | Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome | Infection | 2016 | 40 |
20 | Extracellular Vesicles of Alzheimer’s Disease Patients as a Biomarker for Disease Progression | Molecular Neurobiology | 2020 | 40 |
21 | 15-Lipoxygenases in cancer: A double-edged sword? | Prostaglandins and Other Lipid Mediators | 2013 | 34 |
22 | Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration | Journal of Infection | 2020 | 33 |
23 | A 10‐year experience with treatment of high and standard risk Hodgkin disease: Six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved | American Journal of Hematology | 2012 | 31 |
24 | Richter's transformation to diffuse large B‐cell lymphoma: A retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLLStudy Group | American Journal of Hematology | 2014 | 30 |
25 | Prediction of Chemotherapy-Induced Peripheral Neuropathy in Patients with Lymphoma and Myeloma: the Roles of Brain-Derived Neurotropic Factor Protein Levels and A Gene Polymorphism | Journal of Clinical Neurology (Korea | 2019 | 30 |
26 | Adult Nephrotic Syndrome after Hematopoietic Stem Cell Transplantation: Renal Pathology is the Best Predictor of Response to Therapy | Biology of Blood and Marrow Transplantation | 2016 | 29 |
27 | Safety and Efficacy of CD19-CAR T Cells in Richter's Transformation after Targeted Therapy for Chronic Lymphocytic Leukemia | Blood | 2020 | 29 |
28 | Acute Myeloid Leukemia in Adolescents and Young Adults: Challenging Aspects | Acta Haematologica | 2014 | 28 |
29 | Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable? | Genes Chromosomes and Cancer | 2016 | 28 |
30 | VTE Registry: What Can Be Learned from RIETE? | Rambam Maimonides Medical Journal | 2014 | 27 |
31 | Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance | Cancer Cell International | 2021 | 25 |
32 | Thrombophilia and Adverse Pregnancy Outcome | Obstetrics and Gynecology Clinics of North America | 2006 | 24 |
33 | Acute myeloid leukemia during pregnancy: a systematic review and meta-analysis | Leukemia and Lymphoma | 2018 | 24 |
34 | Extracellular Vesicle Characteristics in β-thalassemia as Potential Biomarkers for Spleen Functional Status and Ineffective Erythropoiesis | Frontiers in Physiology | 2018 | 24 |
35 | Hemostasis and Thrombosis in the Oldest Old | Seminars in Thrombosis and Hemostasis | 2018 | 24 |
36 | Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse | Leukemia and Lymphoma | 2019 | 24 |
37 | The promise of novel direct oral anticoagulants | Best Practice and Research in Clinical Haematology | 2012 | 22 |
38 | Thrombotic complications associated with stem cell transplantation | Blood Reviews | 2012 | 22 |
39 | Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the “3 + 7” induction regimen for acute myeloid leukemia | American Journal of Hematology | 2015 | 22 |
40 | How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia | Haematologica | 2019 | 22 |
41 | Efficacy outcomes in the treatment of older or medically unfit patients with acute myeloid leukaemia: A systematic review and meta-analysis | Leukemia Research | 2019 | 22 |
42 | Thrombophilia and Adverse Pregnancy Outcome | Clinics in Perinatology | 2007 | 21 |
43 | Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome | Bone Marrow Transplantation | 2009 | 21 |
44 | Microvesicles of pregnant women receiving low molecular weight heparin improve trophoblast function | Thrombosis Research | 2016 | 21 |
45 | Abnormal Morphological and Functional Nature of Bone Marrow Stromal Cells Provides Preferential Support for Survival of Acute Myeloid Leukemia Cells | International Journal of Cancer | 2018 | 21 |
46 | The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper | Thrombosis and Haemostasis | 2021 | 21 |
47 | An Update on the Management of Hematologic Malignancies in Pregnancy | Women's Health | 2014 | 20 |
48 | Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice | American Journal of Hematology | 2021 | 20 |
49 | Chemotherapy administration to breast cancer patients affects extracellular vesicles thrombogenicity and function | Oncotarget | 2017 | 20 |
50 | The role of fibrin matrices and tissue factor in early-term trophoblast proliferation and spreading | Thrombosis Research | 2013 | 19 |